Sangro B, Melero I, Yau T, et al. Nivolumab in Sorafenib-Naive and -Experienced Patients With Advanced Hepatocellular Carcinoma (HCC): Survival, Hepatic Safety, and Biomarker Assessments in CheckMate 040. AAASLD 2017, Presidential Poster of Distinction 141.
ASCO GI 2020: nieuwe GE-behandelingen gepaard met betere kwaliteit van leven
apr 2020 | Maag-darm-leveroncologie